Galle Liz 4
4 · CVRx, Inc. · Filed Jan 20, 2023
Insider Transaction Report
Form 4
CVRx, Inc.CVRX
Galle Liz
VP of Global Clinical Research
Transactions
- Award
Stock Option (right to buy)
2023-01-18+26,000→ 26,000 totalExercise: $15.22Exp: 2033-01-17→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter.